Exane Asset Management Pacific Biosciences Of California, Inc. Transaction History

Exane Asset Management

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 Apr 22, 2020	SELL	$2.36 - $5.26 $469,033 - $1.05 Million	-198,743 Closed	0 $0
Q3 2019 Oct 24, 2019	SELL	$4.99 - $6.16 $998,000 - $1.23 Million	-200,000 Reduced 50.16%	198,743 $1.03 Million
Q2 2019 Aug 05, 2019	BUY	$5.92 - $7.41 $1.78 Million - $2.22 Million	300,000 Added 303.82%	398,743 $0
Q1 2019 May 07, 2019	BUY	$6.8 - $7.4 $671,452 - $730,698	98,743 New	98,743 $0

293

253M

1.42M

1.18M

Ticker PACB
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 224,840,992
Market Cap $295M
Description
Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing systems to resolve genetically complex problems. The company provides PacBio's Systems, which conduct, monitor, and analyse biochemical sequencing reactions; consumable products, including single molecule real-time (SMRT) cells; and various reagent kits design...

Get notified when there are updates to the investment portfolio of Exane Asset Management, based on Form 13F filings with the SEC.

Stay updated on Exane Asset Management with notifications on news.